Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology

Berlin / Boston, June 29, 2022 – Bayer AG announced today the opening of its new Research and Innovation Center at Kendall Square in Boston-Cambridge, Massachusetts (U.S.A.), expanding further the company’s footprint into one of the world’s most innovative pharmaceutical research and development locations. Representing a total $140M USD investment into the area…
Read More